Hepatitis B Virus (HBV) Genotypes in an Ecuadorian Population: A Preliminary Study
Chronic hepatitis B virus (HBV) infection affects 257–291 million people worldwide. The World Health Organization reported 890,000 HBV-related deaths in 2019, higher than reported previously. There are 10 HBV genotypes (A–J) subdivided into several subgenotypes that differ considerably by geography....
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Advances in Virology |
Online Access: | http://dx.doi.org/10.1155/2024/8823341 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832543458825338880 |
---|---|
author | Miguel Moncayo Enrique Teran Bernardo Gutierrez Jorge Reyes Johanna Cortez Rodrigo Tobar Gabriela Yerovi Marcia Robalino Ana Aguilar Daniel Garzon-Chavez |
author_facet | Miguel Moncayo Enrique Teran Bernardo Gutierrez Jorge Reyes Johanna Cortez Rodrigo Tobar Gabriela Yerovi Marcia Robalino Ana Aguilar Daniel Garzon-Chavez |
author_sort | Miguel Moncayo |
collection | DOAJ |
description | Chronic hepatitis B virus (HBV) infection affects 257–291 million people worldwide. The World Health Organization reported 890,000 HBV-related deaths in 2019, higher than reported previously. There are 10 HBV genotypes (A–J) subdivided into several subgenotypes that differ considerably by geography. Various virologic factors, including genotype and subgenotype, impact the odds of acquiring a chronic HBV infection, the type of treatment prescribed, and the risk of developing hepatocarcinoma. Information on the HBV genotypes and subgenotypes that circulate in Ecuador remains low. To address this gap, the current study took a preliminary look at HBV-infected human samples from this region to identify the most common genotypes and subgenotypes. Samples from 44 patients in the Andean, Coastal, and Amazon regions of Ecuador were amplified and two major genotypes were identified, genotype F (42/44; 95.5%) and genotype E (2 patients; 4.5%). The genotype F subgenotypes were F3 (35/42; 83.33%), F4 (6/42; 14.28%), and F1b (1/42, 2.39%). This is the first epidemiological study to assess the distribution of HBV genotypes in Ecuador. The findings can inform antiviral drug effectivity studies specific to HBV genotypes prevalent in South America. |
format | Article |
id | doaj-art-dc6b0a075d2c41848a16be785ede9184 |
institution | Kabale University |
issn | 1687-8647 |
language | English |
publishDate | 2024-01-01 |
publisher | Wiley |
record_format | Article |
series | Advances in Virology |
spelling | doaj-art-dc6b0a075d2c41848a16be785ede91842025-02-03T11:40:37ZengWileyAdvances in Virology1687-86472024-01-01202410.1155/2024/8823341Hepatitis B Virus (HBV) Genotypes in an Ecuadorian Population: A Preliminary StudyMiguel Moncayo0Enrique Teran1Bernardo Gutierrez2Jorge Reyes3Johanna Cortez4Rodrigo Tobar5Gabriela Yerovi6Marcia Robalino7Ana Aguilar8Daniel Garzon-Chavez9Universidad San Francisco de Quito USFQUniversidad San Francisco de Quito USFQUniversidad San Francisco de Quito USFQUniversidad Central del EcuadorLaboratorio Clínico Dr. Alberto Moncayo CaleroMinisterio de Salud Pública del EcuadorMinisterio de Salud Pública del EcuadorMinisterio de Salud Pública del EcuadorUniversidad San Francisco de Quito USFQUniversidad San Francisco de Quito USFQChronic hepatitis B virus (HBV) infection affects 257–291 million people worldwide. The World Health Organization reported 890,000 HBV-related deaths in 2019, higher than reported previously. There are 10 HBV genotypes (A–J) subdivided into several subgenotypes that differ considerably by geography. Various virologic factors, including genotype and subgenotype, impact the odds of acquiring a chronic HBV infection, the type of treatment prescribed, and the risk of developing hepatocarcinoma. Information on the HBV genotypes and subgenotypes that circulate in Ecuador remains low. To address this gap, the current study took a preliminary look at HBV-infected human samples from this region to identify the most common genotypes and subgenotypes. Samples from 44 patients in the Andean, Coastal, and Amazon regions of Ecuador were amplified and two major genotypes were identified, genotype F (42/44; 95.5%) and genotype E (2 patients; 4.5%). The genotype F subgenotypes were F3 (35/42; 83.33%), F4 (6/42; 14.28%), and F1b (1/42, 2.39%). This is the first epidemiological study to assess the distribution of HBV genotypes in Ecuador. The findings can inform antiviral drug effectivity studies specific to HBV genotypes prevalent in South America.http://dx.doi.org/10.1155/2024/8823341 |
spellingShingle | Miguel Moncayo Enrique Teran Bernardo Gutierrez Jorge Reyes Johanna Cortez Rodrigo Tobar Gabriela Yerovi Marcia Robalino Ana Aguilar Daniel Garzon-Chavez Hepatitis B Virus (HBV) Genotypes in an Ecuadorian Population: A Preliminary Study Advances in Virology |
title | Hepatitis B Virus (HBV) Genotypes in an Ecuadorian Population: A Preliminary Study |
title_full | Hepatitis B Virus (HBV) Genotypes in an Ecuadorian Population: A Preliminary Study |
title_fullStr | Hepatitis B Virus (HBV) Genotypes in an Ecuadorian Population: A Preliminary Study |
title_full_unstemmed | Hepatitis B Virus (HBV) Genotypes in an Ecuadorian Population: A Preliminary Study |
title_short | Hepatitis B Virus (HBV) Genotypes in an Ecuadorian Population: A Preliminary Study |
title_sort | hepatitis b virus hbv genotypes in an ecuadorian population a preliminary study |
url | http://dx.doi.org/10.1155/2024/8823341 |
work_keys_str_mv | AT miguelmoncayo hepatitisbvirushbvgenotypesinanecuadorianpopulationapreliminarystudy AT enriqueteran hepatitisbvirushbvgenotypesinanecuadorianpopulationapreliminarystudy AT bernardogutierrez hepatitisbvirushbvgenotypesinanecuadorianpopulationapreliminarystudy AT jorgereyes hepatitisbvirushbvgenotypesinanecuadorianpopulationapreliminarystudy AT johannacortez hepatitisbvirushbvgenotypesinanecuadorianpopulationapreliminarystudy AT rodrigotobar hepatitisbvirushbvgenotypesinanecuadorianpopulationapreliminarystudy AT gabrielayerovi hepatitisbvirushbvgenotypesinanecuadorianpopulationapreliminarystudy AT marciarobalino hepatitisbvirushbvgenotypesinanecuadorianpopulationapreliminarystudy AT anaaguilar hepatitisbvirushbvgenotypesinanecuadorianpopulationapreliminarystudy AT danielgarzonchavez hepatitisbvirushbvgenotypesinanecuadorianpopulationapreliminarystudy |